LICN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Lichen International Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of traditional Chinese medicine (TCM) products in the People’s Republic of China. The company offers TCM products in various dosage forms, including tablets, capsules, granules, and or...Show More
Ethical Profile
Lichen International Limited received a Nasdaq delisting notice due to its stock price falling below compliance levels, which has been linked to concerns about business operations. For other ethical areas, including fair pay, worker respect, and environmental impact, there is insufficient public information to assess the company's performance. The company primarily offers financial and taxation consulting, education support, and software solutions.
Similar Companies
The provided articles offer no specific, concrete data points for any of the 'Better Health for All' KPIs. explicitly states that crucial metrics for assessing the company's health impact, including health impact core, harmful revenue share, safety record, price accessibility, and others, are 'absent'.
No evidence available to assess Lichen International Limited on Fair Money & Economic Opportunity.
No data is available in the provided articles regarding Lichen International Limited's performance on any of the Fair Pay & Worker Respect KPIs, including living wage coverage, CEO-median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.
No evidence available to assess Lichen International Limited on Fair Trade & Ethical Sourcing.
No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles primarily discuss Nasdaq delisting notices due to stock price issues and corporate financial activities.
No evidence available to assess Lichen International Limited on Kind to Animals.
No articles provided specific, concrete evidence or data points for Lichen International Limited (LICN.US) regarding any of the 'No War, No Weapons' KPIs. The provided articles either pertain to other companies (F5, Greif)
No specific, quantitative, or outcome-based evidence was found in the provided articles to assess Lichen International Limited against any of the Planet-Friendly Business KPIs. While one article mentions the company uses lichens and mosses for atmospheric mercury level tracking.
No specific, concrete data points were found in the provided articles regarding Lichen International Limited's performance related to Respect for Cultures & Communities. The articles focus on financial performance, stock market activities, and corporate actions like a reverse stock split and name change, without detailing any metrics on community engagement, cultural preservation, or related social responsibility initiatives.
The company extensively discusses its regulatory compliance with Chinese laws and regulations, including those related to foreign investment, taxation, foreign exchange, and cybersecurity.
No evidence available to assess Lichen International Limited on Zero Waste & Sustainable Products.
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.